Skip to main content
    Z

    Zoetis Inc (ZTS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $84.42
    +0.61 (+0.72%)

    Market Cap: $34.06B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Zoetis Inc (ZTS) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Zoetis (ZTS) trades at 12.7x trailing earnings and 3.7x sales. Its P/E of 12.7x is below its 5-year median of 31.4x. Its forward P/E is 12.7x. The median P/E across 10 similar companies is 21.8x.

    Current Multiples

    Its enterprise value is 11.1x its EBITDA. Its free cash flow yield is 6.6%.

    MultipleValue
    P/E (trailing)12.7x
    Forward P/E12.7x
    Price to sales3.7x
    Price to book10.5x
    EV/EBITDA11.1x
    Price to FCF15.3x
    EV/FCF18.6x
    PEG4.0
    FCF yield6.6%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 60.2% below 31.9x, its P/S is 58.4% below 8.9x and its P/B is 41.7% below 18.0x.

    MultipleCurrent5-year median10-year median
    P/E12.7x31.4x31.9x
    P/S3.7x8.9x8.9x
    P/B10.5x16.0x18.0x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 19.6x in 2025 to 51.9x in 2021. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$125.8219.6x5.9x16.6x
    2024$162.9327.5x8.0x15.4x
    2023$197.3737.1x10.7x18.2x
    2022$146.5530.0x8.5x15.5x
    2021$244.0351.9x14.9x25.5x
    2020$165.5043.0x11.8x21.0x
    2019$132.3536.4x10.1x23.5x
    2018$85.5427.2x7.1x19.0x
    2017$72.0430.0x6.7x20.0x
    2016$53.5327.3x5.4x17.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ZTS

    What is ZTS's forward P/E ratio?

    Zoetis has a forward P/E ratio of 12.7x.

    Is ZTS stock overvalued?

    GNG's valuation label for ZTS is Undervalued. Its P/E of 12.7x compares with a median of 21.8x across 10 similar companies.

    What is ZTS's price to sales ratio?

    Zoetis has a price to sales ratio of 3.7x.

    What is Zoetis's average P/E ratio over 5 years?

    Zoetis's median P/E over the last 5 years is 31.4x, from 60 month-end values through Oct 2026.

    What is ZTS's PEG ratio?

    Zoetis has a PEG ratio of 4.0.